This Wednesday, FDA will host an informational webinar about the Draft Guidance to Industry on Drug Development for ME/CFS. I hope you can attend and learn more about the Guidance document, because public comments are due May 12, 2014! This document is the major outcome from last year’s Drug Development meeting, and it is really critical that we provide our input before the document is finalized.
- You can read the Guidance document here.
- The webinar is at 1pm Eastern on Wednesday, April 23rd. No registration is necessary, although there is a capacity limit (added 4/22/14 – capacity limit is 1,000 people). Questions will be accepted during the webinar, and it will be recorded.
- My initial review of the Guidance document is here.
I will post a summary of the webinar and my own public comments on the document by the end of the week (I hope!).